BusinessPredictive Technology Group, Inc. (PRED) Evaluates Up-Listing Trading Status to OTCQBBy Nasdaq OMXSep 11, 2017, 12:59 PM UTC
BusinessTeneobio’s Next Generation T Cell Redirection Antibody Platform for Cancer Biotherapeutics Offers Prospects of Reducing Cytokine ReleaseBy Nasdaq OMXMay 1, 2017, 12:01 PM UTC
BusinessOnconova Therapeutics Announces Closing of Public Offering of Common StockBy Nasdaq OMXApr 26, 2017, 9:26 PM UTC
